Pulmonary embolism after sequential use of recombinant factor VIIa and activated prothrombin complex concentrate in a factor VIII inhibitor patient.
Rosenfeld
Stephan B
SB
Watkinson
Karla K
KK
Thompson
Brad H
BH
Macfarlane
Donald E
DE
Lentz
Steven R
SR
D000328:Adult; D001779:Blood Coagulation Factors / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005169:Factor VIII / Q000276:immunology*; D015942:Factor VIIa / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D006467:Hemophilia A / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D007518:Isoantibodies / Q000276:immunology; D008297:Male; D011655:Pulmonary Embolism / Q000139:chemically induced*; D011993:Recombinant Fusion Proteins / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use
D001779:Blood Coagulation Factors; D007518:Isoantibodies; D011993:Recombinant Fusion Proteins; C025667:prothrombin complex concentrates; D005169:Factor VIII; D015942:Factor VIIa